<DOC>
	<DOCNO>NCT01385683</DOCNO>
	<brief_summary>Dabigatran ( Pradaxa Â® ) new oral anticoagulant . It use prevent venous thromboembolism orthopedic surgery recently demonstrate efficacy safety least good anticoagulant prevention thromboembolism atrial fibrillation treatment venous thromboembolism . It administer fix dose require laboratory monitoring low inter intra individual pharmacokinetic ( PK ) pharmacodynamics ( PD ) dabigatran . However , bioavailability dabigatran low ( 6.5 % ) control efflux protein , P-GP . This molecule genetic polymorphism . The inhibition protein cause significant increase intestinal absorption dabigatran expose patient risk bleed overdose . Two major drug interaction identify : quinidine ( cons-indication ) amiodarone ( precaution ) . It likely interaction exist clinically significant patient select test . The development tool study influence P-GP PK PD dabigatran therefore interesting . As P-GP genetic polymorphism , study latter important element detection drug interaction . In sense , clarithromycin , potent inhibitor P-GP good model evaluate primary mechanism drug interaction dabigatran optimize experimental design study conduct .</brief_summary>
	<brief_title>Investigation Drug-drug Interaction Between Dabigatran Clarithromycin</brief_title>
	<detailed_description />
	<mesh_term>Dabigatran</mesh_term>
	<mesh_term>Clarithromycin</mesh_term>
	<criteria>affiliated beneficiary social security category sign inform consent form sign genetic consent form weight 60 85 kg normal clinical exam normal biological exam contraindication dabigatran contraindication clarithromycin previous history psychiatric disease , antidepressant treatment , convulsion , hemorrhagic disease smoker peptic ulcer severe liver disease severe kidney failure previous surgery within one month</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>March 2012</verification_date>
	<keyword>Healthy volunteer</keyword>
	<keyword>Pharmacokinetic</keyword>
	<keyword>pharmacodynamic</keyword>
	<keyword>Polymorphism , Genetic</keyword>
</DOC>